{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:18:36Z","timestamp":1787980716896,"version":"build-2784847793"},"reference-count":20,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet. Sci.","Veterinary Sciences"],"abstract":"<jats:p>Canine urothelial carcinoma (UC) is commonly managed with non-steroidal anti-inflammatory drugs (NSAIDs), alone or combined with cytotoxic chemotherapy. Evidence supporting subcutaneous keyhole limpet hemocyanin (KLH) in canine UC is lacking. We describe two client-owned dogs with presumptive lower urinary tract UC managed with NSAIDs, KLH, and selenium after cytotoxic chemotherapy was declined. Case 1 was an 11-year-7-month-old castrated male Maltese with bladder-neck\/proximal-urethral thickening. A positive veterinary bladder tumor antigen test, compatible serial imaging, and low-cellularity urine cytology showing suspected urothelial hyperplasia with dysplasia supported clinical suspicion; however, BRAF and BRAF-PLUS assays were negative and histopathology was unavailable. Case 2 was an 11-year-old neutered male Poodle with a BRAF V595E-positive urethrovesical-junction lesion on imaging, without histopathologic confirmation. Both dogs received NSAIDs, Immucothel\u00ae (1 mg subcutaneously), intravenous sodium selenite (200 \u03bcg\/kg), and oral selenium (100 \u03bcg\/dog q24h). Serial CT and ultrasonography documented persistent localized abnormalities over prolonged follow-up, but measurements obtained by different modalities were not treated as directly comparable. Adverse events were assessed retrospectively and not prospectively graded using VCOG-CTCAE criteria. Because the diagnoses were presumptive and the interventions were concurrent and uncontrolled, the independent contribution, efficacy, and safety of KLH cannot be determined. These cases are descriptive and hypothesis-generating.<\/jats:p>","DOI":"10.3390\/vetsci13090878","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:47:13Z","timestamp":1787849233000},"page":"878","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Keyhole Limpet Hemocyanin-Based Multimodal Management in Two Dogs with Presumptive Urothelial Carcinoma: Long-Term Clinical and Imaging Follow-Up"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1159-3715","authenticated-orcid":false,"given":"Ji-hee","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea"},{"name":"Top Care Animal Medical Center, Goyang 10500, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Top Care Animal Medical Center, Goyang 10500, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-2035","authenticated-orcid":false,"given":"Kun-Ho","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1939-1676.2003.tb02424.x","article-title":"Canine transitional cell carcinoma","volume":"17","author":"Mutsaers","year":"2003","journal-title":"J. Vet. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tvjl.2015.01.017","article-title":"Management of transitional cell carcinoma of the urinary bladder in dogs: A review","volume":"205","author":"Fulkerson","year":"2015","journal-title":"Vet. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1078-1439(99)00006-X","article-title":"Naturally occurring canine transitional cell carcinoma of the urinary bladder: A relevant model of human invasive bladder cancer","volume":"5","author":"Knapp","year":"2000","journal-title":"Urol. Oncol."},{"key":"ref_4","first-page":"133","article-title":"Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy","volume":"62","author":"Bradbury","year":"2021","journal-title":"Can. Vet. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jvim.12013","article-title":"Randomized trial of cisplatin versus firocoxib versus cisplatin\/firocoxib in dogs with transitional cell carcinoma of the urinary bladder","volume":"27","author":"Knapp","year":"2013","journal-title":"J. Vet. Intern. Med."},{"key":"ref_6","first-page":"906","article-title":"Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma","volume":"9","author":"Henry","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jsap.12009","article-title":"Retrospective evaluation of doxorubicin\u2013piroxicam combination for the treatment of transitional cell carcinoma in dogs","volume":"54","author":"Robat","year":"2013","journal-title":"J. Small Anim. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jvim.12594","article-title":"Early tumor response to intraarterial or intravenous administration of carboplatin to treat naturally occurring lower urinary tract carcinoma in dogs","volume":"29","author":"Culp","year":"2015","journal-title":"J. Vet. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/BLC-150044","article-title":"A nonselective cyclooxygenase inhibitor enhances the activity of vinblastine in a naturally occurring canine model of invasive urothelial carcinoma","volume":"2","author":"Knapp","year":"2016","journal-title":"Bladder Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1541-7786.MCR-14-0689","article-title":"Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer\u2014Evidence for a relevant model system and urine-based diagnostic test","volume":"13","author":"Decker","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mochizuki, H., Kennedy, K., Shapiro, S.G., and Breen, M. (2015). BRAF mutations in canine cancers. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129534"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Appenzeller, M., Kehl, A., T\u00f6rner, K., Jensen, K.C., Klopfleisch, R., and Aupperle-Lellbach, H. (2025). BRAF mutation analysis: A retrospective evaluation of 8365 diagnostic samples with a special view on canine breeds (2018\u20132024). Vet. Sci., 12.","DOI":"10.3390\/vetsci12080729"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0022-5347(17)42610-3","article-title":"Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: A randomized study","volume":"139","author":"Jurincic","year":"1988","journal-title":"J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000052393","article-title":"Efficacy of prophylactic Immucothel in patients pretreated with conventional drugs to prevent recurrence of superficial bladder carcinoma","volume":"37","author":"Echarti","year":"2000","journal-title":"Eur. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00295189","article-title":"Keyhole limpet hemocyanin immunotherapy of murine bladder cancer","volume":"21","author":"Lamm","year":"1993","journal-title":"Urol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00256891","article-title":"Keyhole-limpet haemocyanin and immune ribonucleic acid immunotherapy of murine transitional cell carcinoma","volume":"9","author":"Lamm","year":"1981","journal-title":"Urol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kim, S.J., Choi, M.C., Park, J.M., and Chung, A.S. (2021). Antitumor effects of selenium. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111844"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zentrichov\u00e1, V., Pechova, A., and Kova\u0159\u00edkov\u00e1, S. (2021). Selenium and dogs: A systematic review. Animals, 11.","DOI":"10.3390\/ani11020418"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/vco.12677","article-title":"Veterinary Cooperative Oncology Group\u2014Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats","volume":"19","author":"LeBlanc","year":"2021","journal-title":"Vet. Comp. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/jvim.16994","article-title":"Reason for euthanasia in dogs with urothelial carcinoma treated with chemotherapy or radiation therapy or both: A retrospective observational study","volume":"38","author":"McKenna","year":"2024","journal-title":"J. Vet. Intern. Med."}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/13\/9\/878\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:40:52Z","timestamp":1787978452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/13\/9\/878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vetsci13090878"],"URL":"https:\/\/doi.org\/10.3390\/vetsci13090878","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}